Lavelle primarily focuses on developing injectable and mucosal vaccines for infectious diseases, along with therapeutic vaccines for cancer.
Read more: Trinity’s Prof Ed Lavelle recognised by ISI for vaccine research
Lavelle primarily focuses on developing injectable and mucosal vaccines for infectious diseases, along with therapeutic vaccines for cancer.
Read more: Trinity’s Prof Ed Lavelle recognised by ISI for vaccine research
